Brief: Immunovant Q3 Net Income USD -111.122 Million
Brief: Immunovant Inc Selling Stockholders To Offer Up To 5.7 Million Shares Of Common Stock- SEC Filing
Brief: Immunovant Announces $450 Million Private Placement
Immunovant Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: Immunovant Provides Development Updates And Reports Financial Results For The Quarter Ended September 30, 2024
Brief: Immunovant Q2 Net Income USD -109.119 Million
Brief: Immunovant Provides Update On Graves' Disease Development Program
Immunovant Inc reports results for the quarter ended in June - Earnings Summary
U.S. RESEARCH ROUNDUP-Amphastar Pharmaceuticals, Guardant Health, Upwork
Brief: Immunovant Q1 Net Income USD -87.15 Million
Immunovant Inc expected to post a loss of 53 cents a share - Earnings Preview
Immunovant Inc expected to post a loss of 43 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Advance Auto Parts, Illumina, Reddit
Immunovant and Argenx rise as rival Chugai's data fails to impress
Brief: Immunovant Awarded U.S. Patent For Imvt-1402
U.S. RESEARCH ROUNDUP-Ball, Couchbase, Holley
Immunovant Inc expected to post a loss of 43 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Cintas Corp, Carnival, Tri Pointe Homes
U.S. STOCKS ON THE MOVE-Emeren Group, Delta Airlines, Annexon Inc